Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The combination of arginine and zinc reduces hair loss and increases hair growth effectively.

Antiandrogen therapy helps treat genetic hair loss.

Fludalanine failed as an effective oral antibiotic despite efforts.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

5-aminosalicylic acid enemas may cause hair loss.

Finasteride niosomes were developed and found to be effective in treating hair loss, with better results than commercial minoxidil, and could be a promising topical treatment for hair loss.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

Sper-12 nanoparticles may help treat hair loss by delivering siRNA to target androgen receptors.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Biosimilars lower costs but don't significantly improve access.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Blocking DGAT1 reduces oil gland size in mice and dogs, but only mice experience hair loss.

The anti-hangover product may boost enzyme activity to help prevent brain damage.

Azathioprine can cause severe blood issues and hair loss, needing careful monitoring and possible discontinuation.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

PAD type III enzyme is specific to rat skin and hair follicles.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Vasodilators may worsen abdominal aortic aneurysm.

DA-9401 helps protect rat testis from finasteride damage.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

A man with multiple autoimmune diseases developed liver injury from azathioprine, but his liver improved after stopping the drug.